Assessing migraine patients with multifocal pupillographic objective perimetry
| dc.contributor.author | Ali, Eman | |
| dc.contributor.author | Carle, Corinne Frances | |
| dc.contributor.author | Lueck, Christian | |
| dc.contributor.author | Kolic, Maria | |
| dc.contributor.author | Maddess, Ted | |
| dc.date.accessioned | 2022-11-02T02:49:52Z | |
| dc.date.available | 2022-11-02T02:49:52Z | |
| dc.date.issued | 2021 | |
| dc.date.updated | 2021-11-28T07:26:05Z | |
| dc.description.abstract | Background: To establish the effects of stimulating intrinsically-photosensitive retinal ganglion cells (ipRGCs) on migraine severity, and to determine if migraine produces objectively-measured visual field defects. Methods: A randomized, open labelled, crossover study tested migraineurs and normal controls using multifocal pupillographic objective perimetry (mfPOP) with 44 test-regions/eye. A slow blue protocol (BP) stimulated ipRGCs, and a fast yellow protocol (YP) stimulated luminance channels. Migraine diaries assessed migraine severity. Per-region responses were analyzed according to response amplitude and time-to-peak. Results: Thirty-eight migraineurs (42.0 ± 16.5 years, 23 females) and 24 normal controls (39.2 ± 15.2 years, 14 females) were tested. The proportion of subjects developing a migraine did not differ after either protocol, either during the 1st day (odds ratio 1.0; 95% confidence interval 0.2–4.4, p = 0.48) or during the first 3 days after testing (odds ratio 0.8; 95% confidence interval 0.3–2.1, p = 0.68). Migraine days/week did not increase following testing with either protocol in comparison to the baseline week (1.4 ± 1.6 pre-testing (mean ± SD), 1.3 ± 1.4 post-BP, and 1.3 ± 1.2 post-YP; p = 0.96), neither did other measures of severity. Migraine occurring up to 2 weeks before testing significantly lowered amplitudes, − 0.64 ± 0.14 dB (mean ± SE), while triptan use increased amplitudes by 0.45 ± 0.10 dB, both at p < 0.001. Conclusions: Stimulating ipRGCs did not affect migraine occurrence or severity. Pupillary response characteristics were influenced by the occurrence of a recent migraine attack and a history of triptan use. | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 1471-2377 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/277935 | |
| dc.language.iso | en_AU | en_AU |
| dc.provenance | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data | en_AU |
| dc.publisher | BioMed Central | en_AU |
| dc.relation | http://purl.org/au-research/grants/arc/CE0561903 | en_AU |
| dc.rights | © 2021 The authors | en_AU |
| dc.rights.license | Creative Commons Attribution licence | en_AU |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_AU |
| dc.source | BMC Neurology | en_AU |
| dc.subject | Migraine | en_AU |
| dc.subject | Trigeminovascular pathway | en_AU |
| dc.subject | Melanopsin | en_AU |
| dc.subject | Multifocal pupillography | en_AU |
| dc.subject | Photosensitivity | en_AU |
| dc.title | Assessing migraine patients with multifocal pupillographic objective perimetry | en_AU |
| dc.type | Journal article | en_AU |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.issue | 211 | en_AU |
| local.bibliographicCitation.lastpage | 12 | en_AU |
| local.bibliographicCitation.startpage | 1 | en_AU |
| local.contributor.affiliation | Ali, Eman, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Carle, Corinne, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Lueck, Christian, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Kolic, Maria, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Maddess, Ted, College of Health and Medicine, ANU | en_AU |
| local.contributor.authoruid | Ali, Eman, u4798777 | en_AU |
| local.contributor.authoruid | Carle, Corinne, u4117988 | en_AU |
| local.contributor.authoruid | Lueck, Christian, u1807496 | en_AU |
| local.contributor.authoruid | Kolic, Maria, u4385340 | en_AU |
| local.contributor.authoruid | Maddess, Ted, u8103614 | en_AU |
| local.description.notes | Imported from ARIES | en_AU |
| local.identifier.absfor | 320905 - Neurology and neuromuscular diseases | en_AU |
| local.identifier.absseo | 200101 - Diagnosis of human diseases and conditions | en_AU |
| local.identifier.ariespublication | a383154xPUB19627 | en_AU |
| local.identifier.citationvolume | 21 | en_AU |
| local.identifier.doi | 10.1186/s12883-021-02239-z | en_AU |
| local.identifier.scopusID | 2-s2.0-85106947005 | |
| local.publisher.url | https://bmcneurol.biomedcentral.com/ | en_AU |
| local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- Assessing migraine.pdf
- Size:
- 1.35 MB
- Format:
- Adobe Portable Document Format
- Description: